
Sign up to save your podcasts
Or
Dr. Jamie Justice is Executive Director of the newly launched XPRIZE Healthspan, a $101 M international competition to accelerate therapeutics targeting aging biology. In conversation with host Chris Patil, Dr. Justice outlines the motivation, structure, and timeline of the prize, as well as how teams can get involved. She also explains unique aspects of this prize, including the public commentary period, how existing trials can be adapted for competition, functional endpoints, and judging criteria. She also conveys why coordination is needed to overcome barriers and drive investment in longevity R&D. Listeners will gain key insights into this ambitious initiative to catalyze progress translating research into treatments for aging.
Key ideas:
Links:
XPRIZE Healthspan
Email questions, comments, and feedback to [email protected]
Translating Aging on Twitter: @bioagepodcast
BioAge Labs Website bioagelabs.com
BioAge Labs Twitter @bioagelabs
BioAge Labs LinkedIn
5
1111 ratings
Dr. Jamie Justice is Executive Director of the newly launched XPRIZE Healthspan, a $101 M international competition to accelerate therapeutics targeting aging biology. In conversation with host Chris Patil, Dr. Justice outlines the motivation, structure, and timeline of the prize, as well as how teams can get involved. She also explains unique aspects of this prize, including the public commentary period, how existing trials can be adapted for competition, functional endpoints, and judging criteria. She also conveys why coordination is needed to overcome barriers and drive investment in longevity R&D. Listeners will gain key insights into this ambitious initiative to catalyze progress translating research into treatments for aging.
Key ideas:
Links:
XPRIZE Healthspan
Email questions, comments, and feedback to [email protected]
Translating Aging on Twitter: @bioagepodcast
BioAge Labs Website bioagelabs.com
BioAge Labs Twitter @bioagelabs
BioAge Labs LinkedIn
378 Listeners
1,060 Listeners
979 Listeners
2,661 Listeners
122 Listeners
194 Listeners
30 Listeners
426 Listeners
15,405 Listeners
169 Listeners
18 Listeners
517 Listeners
161 Listeners
469 Listeners
32 Listeners